Myriad Genetics Inc (MYGN)

Investing Cash Flow

-$21.90M

TTM · Period ending: · USD

MYGN logo

MYGN Investing Cash Flow

Latest reported-$21.90M
MYGN TTM Cash from Investing (-$8.90M → -$21.90M)
High-resolution chart · PNG

MYGN investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-21,900,000
-25,600,000
-27,400,000
-27,300,000
-13,600,000
-13,100,000
-11,900,000
-18,000,000
-28,000,000
-9,800,000
31,900,000
8,300,000
22,200,000
-1,600,000
-77,500,000
-67,800,000
211,800,000
224,900,000
274,400,000
311,200,000
37,300,000
46,500,000
63,100,000
45,000,000
20,800,000
15,000,000
-13,600,000
-14,500,000
-286,400,000
-282,000,000
-278,900,000
-275,400,000
-11,600,000
-16,200,000
-6,000,000
-3,500,000
-146,300,000
-194,400,000
-220,000,000
-258,400,000
-91,400,000
-50,413,000
-9,413,000
22,387,000
40,887,000
23,839,000
-2,104,000
17,430,000
-18,631,000
-83,399,000
-34,275,000
-79,146,000
-75,590,000
865,000
-91,033,000
-41,361,000
-38,888,000
-91,652,000
-5,355,000
-73,595,000
-54,390,000
18,519,000
-37,390,000
-61,307,000
-76,668,000
-134,603,000
-139,025,000
-163,664,000
-206,342,000
-180,360,000
-142,492,000
-42,656,000
-31,305,000
-69,734,000
-82,829,000
-80,302,000
-46,741,000
3,584,000
-12,428,000
-68,328,000
-72,829,000
-33,078,000
-29,828,000
25,509,000
19,517,000
-19,317,000
-5,159,000
-5,285,000
1,927,000
-8,854,000
-16,056,000
-16,997,000
-11,963,000
3,658,094
14,985,245
22,586,488
38,089,488
-26,099,498
-36,575,060
-49,447,219
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.